Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal and Kyowa Kirin.

Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. Through a network of affiliates and key partners, we are bringing these important products to patients in need around the globe.

Therapeutics

Pharmaceutical

Life Sciences

Health Care

Grünenthal Meds

Grünenthal Meds' headquarters in Galashiels, United Kingdom

Christoph Stolle

Anders Gikling

Nick W.

Kimberly Shields

Business Development and Partner Management

Leadership Team

Supply Chain Management

Grünenthal Meds

Org chart

Teams

Business Development and Partner Management

Leadership Team

Supply Chain Management

Offices

Similar companies